Litcius/Paper detail

Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer

Eva Shrestha, Jonathan B. Coulter, William Guzman, Büşra Özbek, Megan M. Hess, Luke Mummert, Sarah E. Ernst, Janielle P. Maynard, Alan K. Meeker, Christopher M. Heaphy, Michael C. Haffner, Angelo M. De Marzo, Karen S. Sfanos

2021Proceedings of the National Academy of Sciences58 citationsDOIOpen Access PDF

Abstract

messenger RNA by in situ hybridization. We additionally verified TMPRSS2:ERG genomic rearrangements in precursor lesions using tricolor fluorescence in situ hybridization. Identification of rearrangement patterns combined with whole-prostate mapping in three dimensions confirmed multiple (up to eight) distinct ERG+ precancerous lesions in infected cases. We further identified the pathogen-derived genotoxin colibactin as a potential source of DNA breaks in clinical cases as well as cultured prostate cells. Overall, we provide evidence that bacterial infections can initiate driver gene alterations in prostate cancer. In addition, our observations indicate that infection-induced ERG+ fusions are an early alteration in the carcinogenic process and that PIA may serve as a direct precursor to prostate cancer.

Topics & Concepts

TMPRSS2Prostate cancerProstateErgFusion geneCancer researchCancerBiologyMedicineGenePathologyInternal medicineGeneticsDiseaseCoronavirus disease 2019 (COVID-19)NeuroscienceRetinaInfectious disease (medical specialty)Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHepatitis B Virus Studies